Sleep Disorders Trial, Recruiting NCT06319482 Sponsor: NovaResp Technologies Inc Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06319482
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have recently been diagnosed with moderate or severe sleep apnea, meaning their breathing stops or becomes shallow more than 15 times per hour during sleep.
  • People who are between 18 and 70 years old.
  • People who do not have a history of severe heart or brain/nervous system problems that are currently uncontrolled.
  • People who are able to follow all the requirements set out in the study agreement.
  • People who are able to follow instructions from the study doctor and research team.
  • People who can understand English and are willing to sign a consent form agreeing to take part.

Who may not be able to join:

  • People who have previously used a PAP (pressurised air breathing) machine for sleep apnea.
  • People who are currently using a bi-level PAP machine or who need oxygen therapy.
  • People with serious or unstable medical conditions, such as cancer, dementia, unstable heart or lung disease, or unstable mental health conditions.
  • People whose sleep apnea, in the treating clinician's opinion, may pose a risk to their health or safety during the trial.
  • People who are unwilling or unable to provide written consent to participate.
  • People with certain serious medical conditions, including neuromuscular disease, nerve damage affecting the tongue, severe lung disease, moderate-to-severe high blood pressure in the lungs, severe heart valve disease, advanced heart failure, a heart attack or serious irregular heartbeat in the past 6 months, high blood pressure that remains uncontrolled despite medication, active psychiatric illness, or other sleep disorders unrelated to breathing that could affect how sleep is measured.
  • People who are pregnant, planning to become pregnant, or currently breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 902-986-1660

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
NovaResp Technologies Inc
Registry
ClinicalTrials.gov
Start date
16 June 2024
Est. completion
16 June 2025

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Adherence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov